What Is Aluminium Hydroxide USP?

Aluminium Hydroxide USP is a pharmaceutical-grade form of aluminium hydroxide manufactured and tested according to the applicable standards of the United States Pharmacopeia. In USP publications and the US pharmaceutical market, the material is normally spelled “Aluminum Hydroxide,” while “Aluminium Hydroxide” is more commonly used in British and international English.

Aluminium hydroxide is an inorganic aluminium compound generally represented by the chemical formula Al(OH)₃. Pharmaceutical forms may include aluminium hydroxide gel and dried aluminium hydroxide gel, depending on the formulation and manufacturing requirements. USP maintains separate monographs for Aluminum Hydroxide Gel and Dried Aluminum Hydroxide Gel.

What Does USP Grade Mean?

The “USP” designation indicates that the material is intended to comply with the identity, quality, purity, strength and performance requirements established in the relevant USP–NF monograph and applicable general chapters.

USP develops public quality standards for pharmaceutical ingredients, excipients, active pharmaceutical ingredients and finished dosage forms. These standards provide manufacturers, laboratories and regulatory authorities with recognized methods for evaluating whether pharmaceutical materials meet defined quality requirements.

However, a USP-grade designation does not automatically mean that a product has been approved by the US Food and Drug Administration. Buyers should confirm that each batch is supported by appropriate test results, documentation and manufacturing controls.

Pharmaceutical Uses of Aluminium Hydroxide USP

One of the best-known pharmaceutical applications of aluminium hydroxide is as an active ingredient in antacid products. It reacts gradually with hydrochloric acid in the stomach, helping neutralize excess gastric acid.

The FDA OTC Monograph M001 recognizes aluminium hydroxide as one of the permitted active ingredients for over-the-counter antacid products. Finished antacid products must meet applicable formulation, labeling and acid-neutralizing-capacity requirements.

Aluminium hydroxide may be used in:

• Oral antacid suspensions

• Antacid tablets or chewable products

• Aluminium hydroxide and magnesium hydroxide combinations

• Antacid products containing simethicone

• Pharmaceutical formulations requiring aluminium hydroxide gel

• Certain prescription products manufactured under professional supervision

Commercial antacid suspensions frequently combine aluminium hydroxide with magnesium hydroxide. The combination is commonly selected to provide effective acid neutralization while balancing the formulation characteristics of the two ingredients. Current US drug labels identify aluminium hydroxide, equivalent to dried gel USP, as an active antacid ingredient in these products.

The exact application, dosage and formulation must be determined by qualified pharmaceutical professionals in accordance with relevant regulations.

Important Quality Parameters

Pharmaceutical manufacturers should evaluate more than the product name when purchasing Aluminium Hydroxide USP. The exact specification depends on whether the material is supplied as a gel, dried gel or another approved form.

Common quality considerations include:

1. Identification

The material should pass the identification procedures specified in the applicable pharmacopoeial monograph. Identification testing helps confirm that the supplied material is aluminium hydroxide rather than another aluminium compound.

2. Assay or Aluminium Content

The certificate of analysis should state the measured content according to the relevant analytical method. Results must comply with the limits established for the specific pharmaceutical grade and product form.

3. Acid-Neutralizing Capacity

For antacid applications, acid-neutralizing performance is an especially important functional parameter. It can influence dosage-form design, active ingredient quantity and the performance of the finished product.

4. Purity and Impurity Control

Manufacturers should evaluate relevant chemical impurities, elemental impurities and process-related contaminants. USP standards and reference materials are intended to support the verification of pharmaceutical ingredient identity, purity, strength and performance.

5. Physical Properties

Depending on the dosage form, buyers may need to examine particle size, appearance, pH, viscosity, dispersibility, loss on drying and sedimentation characteristics. These properties can affect suspension stability, processing efficiency and finished-product uniformity.

6. Microbiological Quality

When aluminium hydroxide is supplied as an aqueous gel, microbiological controls can be particularly important. The material should be manufactured, packaged and stored under suitable conditions to minimize contamination risks.

Aluminium Hydroxide Gel vs. Dried Gel

Aluminium hydroxide gel is generally supplied as a hydrated, water-containing material. It is commonly considered for liquid pharmaceutical preparations and oral suspensions.

Dried aluminium hydroxide gel contains less water and is usually supplied in powder form. It may be more convenient for transportation, storage and the manufacture of tablets, powders or reconstituted formulations.

These forms should not be substituted solely on a weight-for-weight basis. Their aluminium hydroxide equivalent, moisture content, acid-neutralizing capacity and processing behavior may differ. Formulation manufacturers should verify equivalence through technical evaluation and laboratory testing.

What Documents Should Buyers Request?

When sourcing Aluminium Hydroxide USP, pharmaceutical companies and distributors should request:

• A batch-specific certificate of analysis

• Current USP compliance information

• Safety Data Sheet

• Product specification sheet

• Manufacturing date and retest or expiry date

• Batch number and traceability records

• Information about manufacturing standards

• Packaging and storage instructions

• Elemental impurity or microbiological data when required

• Regulatory support documents for the destination market

The certificate of analysis should clearly identify the tested batch and list the analytical methods, specification limits and actual results.

Packaging and Storage

Aluminium Hydroxide USP should be supplied in clean, tightly closed pharmaceutical-grade packaging that protects it from contamination and environmental exposure. Powder products should generally be protected from moisture, while gel products should be protected from unsuitable temperatures and microbial contamination.

The material should be stored according to the supplier’s instructions and the applicable pharmacopeial requirements. Users should also follow appropriate first-in, first-out inventory procedures and avoid using damaged or improperly sealed packages.

Choosing an Aluminium Hydroxide USP Supplier

A reliable supplier should provide consistent batch quality, complete documentation and technical support. Buyers should evaluate the supplier’s manufacturing controls, laboratory capabilities, traceability system, change-control procedures and ability to support regulatory reviews.

Before placing a bulk order, manufacturers may request a sample for formulation trials and analytical verification. Clear communication about the required product form, pharmacopoeial standard, particle size, packaging, annual quantity and destination market can help prevent specification mismatches.

Aluminium Hydroxide USP is an important pharmaceutical material, particularly for antacid manufacturing. Selecting a properly documented product that meets the applicable USP requirements helps pharmaceutical manufacturers maintain formulation consistency, regulatory compliance and dependable finished-product quality.